Transgene (TGNA) Income Statement
Transgene Income Statement
Last quarter (Q2 2026), Transgene's total revenue was $272.00K, an increase of 1082.61% from the same quarter last year. In Q2, Transgene's net income was $-15.67M. See Transgene’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 490.00K | $ 6.35M | $ 7.90M | $ 3.13M | $ 9.99M | |
| $ 490.00K | $ -27.93M | $ -21.69M | $ -29.04M | $ -22.89M | |
| $ 34.48M | $ 7.73M | $ 8.36M | $ 33.25M | $ 33.74M | |
| Depreciation and Amortization | $ 1.30M | $ 1.28M | $ 1.57M | $ 1.69M | $ 2.52M |
| $ -39.77M | $ -26.65M | $ -28.44M | $ -30.31M | $ -16.55M | |
| $ -41.07M | $ -35.66M | $ -30.05M | $ -29.90M | $ -23.52M | |
| $ -3.17M | $ 1.69M | $ 7.72M | $ -2.90M | $ 4.16M | |
| $ -44.24M | $ -40.02M | $ -22.33M | $ -32.80M | $ -19.54M | |
| $ -37.52M | $ -33.97M | $ -22.33M | $ -32.81M | $ -20.00M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.26 | $ -0.29 | $ -0.22 | $ -0.33 | $ -0.22 |
| Diluted EPS | $ -0.26 | $ -0.29 | $ -0.22 | $ -0.33 | $ -0.22 |
| Weighted Average Shares Outstanding | 144.32M | 116.67M | 100.59M | 99.50M | 91.11M |
| Weighted Average Shares Outstanding (Diluted) | 144.32M | 116.67M | 100.59M | 99.50M | 91.11M |
Currency in EUR
